NASDAQ:MEIP - MEI Pharma Stock Price, Forecast & News

MEI Pharma trades on the NASDAQ under the ticker symbol "MEIP."

MEI Pharma Inc (NASDAQ:MEIP) released its quarterly earnings data on Thursday, November, 7th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.16) by $0.01. The business earned $1.16 million during the quarter, compared to the consensus estimate of $1.11 million. MEI Pharma had a negative net margin of 514.11% and a negative return on equity of 79.27%. View MEI Pharma's Earnings History.

MEI Pharma is scheduled to release their next quarterly earnings announcement on Thursday, February 6th 2020. View Earnings Estimates for MEI Pharma.

3 analysts have issued 12-month price objectives for MEI Pharma's shares. Their forecasts range from $10.00 to $10.00. On average, they anticipate MEI Pharma's stock price to reach $10.00 in the next year. This suggests a possible upside of 296.8% from the stock's current price. View Analyst Price Targets for MEI Pharma.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MEI Pharma in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for MEI Pharma.

Headlines about MEIP stock have trended negative on Saturday, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. MEI Pharma earned a coverage optimism score of -2.0 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for MEI Pharma.

MEI Pharma saw a increase in short interest during the month of December. As of December 31st, there was short interest totalling 367,900 shares, an increase of 25.2% from the December 15th total of 293,800 shares. Based on an average daily volume of 418,900 shares, the short-interest ratio is presently 0.9 days. Currently, 0.6% of the shares of the stock are short sold. View MEI Pharma's Current Options Chain.

Some companies that are related to MEI Pharma include Revance Therapeutics (RVNC), RAPT Therapeutics (RAPT), XBiotech (XBIT), Opko Health (OPK), Gossamer Bio (GOSS), Akebia Therapeutics (AKBA), Amphastar Pharmaceuticals (AMPH), G1 Therapeutics (GTHX), Radius Health (RDUS), Aprea Therapeutics (APRE), Odonate Therapeutics (ODT), Achillion Pharmaceuticals (ACHN), Rhythm Pharmaceuticals (RYTM), Kiniksa Pharmaceuticals (KNSA) and ZIOPHARM Oncology (ZIOP).

Based on aggregate information from My MarketBeat watchlists, some companies that other MEI Pharma investors own include SCYNEXIS (SCYX), Verastem (VSTM), Rigel Pharmaceuticals (RIGL), Synergy Pharmaceuticals (SGYP), Aurinia Pharmaceuticals (AUPH), Actinium Pharmaceuticals (ATNM), Inovio Pharmaceuticals (INO), Novavax (NVAX), TG Therapeutics (TGTX) and Agile Therapeutics (AGRX).

Shares of MEIP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MEIP stock can currently be purchased for approximately $2.52.

MEI Pharma has a market capitalization of $256.48 million and generates $4.91 million in revenue each year. The company earns $-16,820,000.00 in net income (profit) each year or ($0.62) on an earnings per share basis. MEI Pharma employs 32 workers across the globe.View Additional Information About MEI Pharma.

The official website for MEI Pharma is http://www.meipharma.com/.

MEI Pharma's mailing address is 3611 VALLEY CENTER DRIVE, SAN DIEGO CA, 92130. The company can be reached via phone at 858-369-7100 or via email at [email protected]